About Teyro Labs Private Limited
Data last updated:
Teyro Labs Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24100TN2014PTC095150. Its GSTIN is 33AAMCA4396C1ZQ (Tamil Nadu). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹40 Cr and a paid-up capital of ₹36.65 Cr. It was formerly known as Accencis Health Care Private Limited and Accencis Health Private Limited. It is led by directors Jagathrakshakan Swamikannu and Sundeep Anand Jegathrakshagan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.29 Tilak Street T Nagar, Chennai, Tamil Nadu, India – 600017.
As per the financials filed for FY 2024, the company reported a revenue of ₹15 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹23.11 Cr (net margin -154.1%) and EBITDA of ₹30.02 Cr (EBITDA margin 200.1%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 100% over five years.
The company has about 175 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Teyro and Teyro Labs. As per MCA filings, the company has open charges of ₹154.02 Cr on record. Court records list 7 cases involving the company, including 4 filed by the company and 3 filed against it; 2 cases are pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹30 Cr; the latest was in March 2019. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Signa Pharma Private Limited with revenue of ₹2.53 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website teyro.com.
Company details
Name history
Teyro Labs has undergone 4 name changes throughout its history. The current legal name is Teyro Labs Private Limited.
| Company Name | Status |
|---|---|
| Teyro Labs Private Limited | Current |
| Accencis Health Care Private Limited | Previous |
| Accencis Health Private Limited | Previous |
| Accord Life Spec Private Limited | Previous |
| Accord Lifespec Private Limited | Previous |
Contact details
Teyro Labs Private Limited's registered office is in Chennai, Tamil Nadu. Its website is teyro.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo.29 Tilak Street T Nagar, Chennai, Tamil Nadu, India – 600017
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Teyro Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Teyro Labs operates two associated brands: Teyro and Teyro Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in developing and manufacturing oncology pharmaceuticals. | teyro.com | |
| Development and manufacturing of generic pharmaceutical formulations and active ingredients in India. | teyrolabs.com |
Business activity
The main business activity of Teyro Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Teyro Labs Private Limited, buy the company report.
Financials of Teyro Labs Private Limited
FY 2024 filings availableTeyro Labs Private Limited reported revenue of ₹15 Cr (up 498% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 100% over five years, including 498% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹15 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30.02 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹23.11 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 200.1% | ||||
| Net Profit Margin | -154.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Teyro Labs Private Limited, buy the company report.
Board of directors of Teyro Labs Private Limited
Teyro Labs has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagathrakshakan Swamikannu Also directs: The Chrome Leather Company Limited, Accord Lifespec Private Limited, Accord Distillers & Brewers Private Limited and 5 more | Director | 18 Aug 2023 | 3 Years 2 Months | Current |
| Sundeep Anand Jegathrakshagan Also directs: The Chrome Leather Company Limited, Accord Distillers & Brewers Private Limited, Anujasan Private Limited and 5 more | Director | 01 Dec 2014 | 11 Years 10 Months | Current |
Peer comparison
Teyro Labs Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Teyro Labs Private Limitedthis company | ₹15 Cr (FY 2024) | -₹23.11 Cr | -154.1% | 498.0% | 175 | Chennai, Tamil Nadu, India |
| Signa Pharma Private Limited | ₹2.53 Cr (FY 2025) | 0.0% | Uttar Pradesh, India | |||
| Pranjivani Wellness Private Limited | ₹2.52 Cr (FY 2024) | -12.0% | Gurgaon, Haryana, India | |||
| Masks Life Sciences Private Limited | ₹2.51 Cr (FY 2024) | 13.0% | Bangalore, Karnataka, India | |||
| Neutec Healthcare Private Limited | ₹2.5 Cr (FY 2025) | -61.0% | Delhi, India | |||
| Dorphyll Healthcare Private Limited | ₹2.5 Cr (FY 2025) | -1.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Teyro Labs Private Limited, buy the company report.
Auditor
Teyro Labs Private Limited is audited by RRPM & Associates LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RRPM & Associates LLP | FY 2024 | 017126S |
Shareholding
The shareholding of Teyro Labs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Teyro Labs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Nov 2016 | 100077557 | Others | ₹154.02 Cr | Open |
To see the full charge records of Teyro Labs Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Teyro Labs Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹30 Cr; the latest was in March 2019.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Funding round | ₹30 Cr | Investors: J Hotels Private Limited |
| Apr 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Teyro Labs Private Limited has 7 court cases on record: 4 filed by Teyro Labs, 3 filed against it. 2 cases are pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
| NCLAT | 2 | 0 | 2 |
| District courts | 1 | 1 | 0 |
| Supreme Court | 1 | 1 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT New Delhi | Insolvency matter | Filed by the company against M/S. Orchid Pharma Ltd. and 2 others | Pending |
| High Court, TAMIL NADU | Arbitration matter | Filed by the company against M/S. Safelife Pharma Speciality Private Limited, | Disposed |
| District court, South East, Delhi | Civil suit | Filed against the company by Reynold India Pvt Ltd. | Disposed |
| High Court, TAMIL NADU | Original application | Filed by the company against M/S.Safelife Pharma Speciality Private Limited | Disposed |
| NCLT, Chennai | Insolvency matter | Filed against the company by Raksha Building Technologies | Disposed |
To see the full case history of Teyro Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Teyro Labs Private Limited was last rated by Icra on 25 Sep 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 25 Sep 2020 |
To see the full credit ratings and regulatory alerts of Teyro Labs Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Teyro Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Teyro Labs has 1 associated company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
Employees & EPFO
Teyro Labs Private Limited has a workforce of 175 employees on its EPFO records as of Jan 27, 2025, across 1 active EPFO establishment.
GST
Teyro Labs has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAMCA4396C1ZQ | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Teyro Labs Private Limited, buy the company report.
Recent activity
Teyro Labs Private Limited has 6 board changes on record since 2014: 2 appointments and 4 cessations. The latest: Harsh Jhunjhunwala ceased to be Company Secretary on 30 Jun 2024.
Frequently asked questions
Teyro Labs is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 February 2014 (12+ years old) and is registered under CIN U24100TN2014PTC095150.
Teyro Labs has 2 current directors:
- Jagathrakshakan Swamikannu - Director
- Sundeep Anand Jegathrakshagan - Director
The latest financial statements of Teyro Labs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Teyro Labs is 33AAMCA4396C1ZQ, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Teyro Labs is U24100TN2014PTC095150. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Teyro Labs has 7 court cases on record: 4 filed by the company and 3 filed against it. 2 are pending. Most are in the high courts.
Teyro Labs was incorporated on 21 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Chennai.
Teyro Labs has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹30 Cr; the latest was in March 2019.
The peers of Teyro Labs by revenue are Signa Pharma Private Limited, Pranjivani Wellness Private Limited, Masks Life Sciences Private Limited, Neutec Healthcare Private Limited, Dorphyll Healthcare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Harsh Jhunjhunwala ceased to be Company Secretary on 30 Jun 2024. Srinisha Jagathrakshakan ceased to be Director on 19 Aug 2023. Jagathrakshakan Swamikannu was appointed as Director on 18 Aug 2023. Teyro Labs has 6 board changes on record in total.
Teyro Labs can be reached through the website teyro.com. Its registered office is in Chennai, Tamil Nadu, India.